Hit-to-lead optimization and kinase selectivity of imidazo[1,2-a]quinoxalin-4-amine derived JNK1 inhibitors.
Li B, Cociorva OM, Nomanbhoy T, Weissig H, Li Q, Nakamura K, Liyanage M, Zhang MC, Shih AY, Aban A, Hu Y, Cajica J, Pham L, Kozarich JW, Shreder KR.
Li B, et al. Among authors: aban a.
Bioorg Med Chem Lett. 2013 Sep 15;23(18):5217-22. doi: 10.1016/j.bmcl.2013.06.087. Epub 2013 Jul 8.
Bioorg Med Chem Lett. 2013.
PMID: 23916259